Characterisation of HIV-1 infection of immune cells

  • Research type

    Research Study

  • Full title

    Characterisation of HIV-1 infection of immune cells

  • IRAS ID

    229855

  • Contact name

    Q Sattentau

  • Contact email

    quentin.sattentau@path.ox.ac.uk

  • Sponsor organisation

    University of Oxford

  • Clinicaltrials.gov Identifier

    N/A, N/A

  • Duration of Study in the UK

    2 years, 1 months, 28 days

  • Research summary

    The aims of this project are two-fold. Firstly, to investigate the signals involved in uptake of HIV-1-infected T cells by macrophages. Secondly, to study the effects of HIV-1 infection on monocyte/macrophage activation and trafficking. The results of the study will help to shed light on the mechanism of establishment of the macrophage reservoir and HIV-1 dissemination in vivo and provide potential targets for anti-inflammatory therapies adjunctive to antiretroviral therapy.
    To achieve this blood will be taken from healthy volunteers recruited from the University of Oxford by department-wide email lists by a trained member of staff following acquisition of informed consent. In addition blood will also be obtained from the NHSBT, which already has informed consent for use of these samples in research. Once acquired, the blood will be anonymised and processed to obtain the peripheral blood mononuclear cells (PBMCs). These cells will then be cultured and infected and analysed to address the questions described above.
    This work has been reviewed and funded by the Wellcome Trust Infection, Immunity and Translational Medicine PhD program and the Edward P Abraham Trust PhD program.

  • REC name

    West Midlands - Coventry & Warwickshire Research Ethics Committee

  • REC reference

    17/WM/0333

  • Date of REC Opinion

    22 Aug 2017

  • REC opinion

    Favourable Opinion